Search Results 1401-1410 of 18380 for Lupus

1. Tremelimumab-actl (intravenous route) - Side effects & uses - Mayo Clinic

   Adrenal gland problems or; Diabetes or; Immune system problems (eg, Crohn's disease, ulcerative colitis, lupus) or; Kidney problems or; Nervous system problems ...

2. Rem-422, an MYB mRNA Degrader, in Patients With Relapsed/Refractory AML or Higher-Risk MDS - Mayo Clinic

   History or current autoimmune disease requiring systemic treatment (eg, Crohn disease, ulcerative colitis, rheumatoid arthritis, systemic lupus). 33 ...

3. CAR-T Cell Therapy Program - Overview - Mayo Clinic

   Relapsed, refractory follicular lymphoma; Relapsed, refractory multiple myeloma; Other types of cancer and medical conditions undergoing clinical studies. If ...

4. Rituximab Vasculitis Maintenance Study - Clinical Trials

   Presence of another multisystem autoimmune disease, including Churg Strauss syndrome, systemic lupus erythematosus, anti-GBM disease, or cryoglobulinaemic ...

5. Autoimmune encephalitis - Symptoms and causes - Mayo Clinic

   Learn how the immune system mistakenly attacks brain cells to cause swelling in the brain related to this group of conditions.

6. Radiation Therapy with Durvalumab or Cetuximab to Treat Patients with Locoregionally Advanced Head and Neck Cancer who Cannot Take Cisplatin - Mayo Clinic

   ... lupus erythematosus, Sarcoidosis syndrome, or Wegener syndrome [granulomatosis with polyangiitis, Graves' disease, rheumatoid arthritis, hypophysitis ...

7. A Study to Evaluate the Safety, Tolerability, and Determine the Optimal Dose for the Expansion Cohorts of VSV-IFNβ-NIS in Combination with Pembrolizumab in Patients with Refractory Solid Tumors - Mayo Clinic

   Any known or suspected active organ-threatening autoimmune disease, such as inflammatory bowel disease, autoimmune hepatitis, lupus, or pneumonitis, with ...

8. Rheumatoid Arthritis Clinical Trials

   ... lupus erythematosus (SLE), rheumatoid arthritis (RA), and anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis using primary samples and/or ...

9. Phase II Randomized Trial Comparing GA101 and Rituximab in Untreated Low Tumor Burden Indolent Non-Hodgkin's Lymphoma - Mayo Clinic

   PTT (Partial Thromboplastin Time) or aPTT (activated Partial Thromboplastin Time) >1.5x the ULN in the absence of a lupus anticoagulant; INR (International ...

10. Pharmacokinetic and Safety Study of Nab ®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects with Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubenemia - Mayo Clinic

    History of connective tissue disorders (eg, lupus, scleroderma, arteritis nodosa). Subjects with a history of interstitial lung disease, history of slowly ...